High-dose-rate brachytherapy boost for prostate cancer: Comparison of two different fractionation schemes

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 222-227

  Kaprealian, Tania ^a   Weinberg, Vivian ^b   Speight, Joycelyn L ^a   Gottschalk, Alexander R ^a   Roach III, MacK ^a   Shinohara, Katsuto ^a   Hsu, I Chow ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Boost; Brachytherapy; High dose rate; Prostate cancer; Radiation therapy

Indexed keywords

BOOST; BRACHYTHERAPY; EXTERNAL BEAM RADIATION THERAPY; GLEASON SCORES; HDR BRACHYTHERAPY; HIGH DOSE RATE; HIGH-DOSE-RATE BRACHYTHERAPY; HIGH-RISK PATIENTS; KAPLAN-MEIER ESTIMATES; PRE-TREATMENT; PROGRESSION FREE SURVIVAL; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN;

DISEASES; ONCOLOGY;

RADIOTHERAPY;

ANTIANDROGEN; ANTINEOPLASTIC AGENT; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANEMIA; ARTICLE; B CELL LYMPHOMA; BLADDER CANCER; BLADDER CARCINOMA; BLADDER CATHETERIZATION; BLADDER FISTULA; BLOOD TRANSFUSION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HEMATURIA; HIGH RISK PATIENT; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROGENIC BLADDER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM FISTULA; RETROSPECTIVE STUDY; STRESS INCONTINENCE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT FAILURE; URINARY TRACT OBSTRUCTION; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FIDUCIAL MARKERS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 83955161795     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.021     Document Type: Article

References (22)

1. M.A. Bagshaw, R.S. Cox, and G.R. Ray Status of radiation treatment of prostate cancer at Stanford University NCI Monogr 7 1988 47 60
2. A.A. Perez, M.V. Pilepich, and F. Zivnuska Tumor control in definitive irradiation of localized carcinoma of the prostate Int J Radiat Oncol Biol Phys 12 1986 523 531
3. G.E. Hanks, J.J. Diamond, J.M. Krall, K.L. Martz, and S. Kramer A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States Int J Radiat Oncol Biol Phys 13 1987 499 505
4. G.K. Zagars, A.C. von Eschenbach, D.E. Johnson, and M.J. Oswald Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation Cancer 60 1987 1489 1499
5. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
6. J.R. Sathya, I.R. Davis, and J.A. Julian Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 2005 1192 1199
7. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 2005 1233 1239
8. D.P. Dearnaley, M.R. Sydes, and J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487
9. A. Al-Mamgani, W.L. van Putten, and W.D. Heemsbergen Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 980 988
10. P.J. Hoskin, K. Motohashi, P. Bownes, L. Bryant, and P. Ostler High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial Radiother Oncol 84 2007 114 120
11. V. Beckendorf, S. Guerif, and E. Le Prise 70 Gy vs 80 Gy dose escalation GETUG 06 French Trial for Localized Prostate Cancer: mature results Int J Radiat Oncol Biol Phys 72 Suppl 2008 S96 S97
12. C.E. Vargas, A.A. Martinez, and T.P. Boike High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study Int J Radiat Oncol Biol Phys 66 2006 416 423
13. I.C. Hsu, A.R. Cabrera, and V. Weinberg Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer Brachytherapy 4 2005 202 206
14. M. Roach 3rd, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911
15. M. Roach 3rd, C. Marquez, and H.S. Yuo Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 28 1994 33 37
16. I.C. Hsu, E. Lessard, V. Weinberg, and J. Pouliot Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy Brachytherapy 3 2004 147 152
17. C.L. Holloway, I.-C. Hsu, and M. Albert Prostate brachytherapy P.M. Devlin, Brachytherapy applications and techniques 2007 Lippincott Williams & Wilkins Philadelphia 181 222
18. Y. Kim, I.C. Hsu, E. Lessard, J. Pouliot, and J. Vujic Dose uncertainty due to computed tomography (CT) slice thickness in CT-based high dose rate brachytherapy of the prostate cancer Med Phys 31 2004 2543 2548
19. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormone therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
20. I.C. Hsu, B. Kyounghwa, and K. Shinohara Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: Preliminary results of RTOG 0321 Int J Radiat Oncol Biol Phys 78 3 2010 751 758 Epub 2010
21. F. Mallet, D. Wdowczyk, and A. Bruna [Feasibility and toxicity of a single fraction high-dose-rate brachytherapy followed by a course of EBRT for localized prostate cancer: a retrospective study. The Polyclinique Courlancy experience] Cancer Radiother 14 2010 11 18
22. G.C. Morton, D.A. Loblaw, and R. Sankreacha Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life Int J Radiat Oncol Biol Phys 77 2010 811 817